Disparities in the overdose crisis? A comparison of Black and White communities in America Recovery Research Institute

Volkow points to a recent NIH study as proof that starting substance disorder treatment during incarceration lowers the risk of probation violations and reincarcerations and improves the chances of recovery. But only one in 13 prisoners with substance use problems receives treatment, according to a Pew data analysis. University of Cincinnati psychologist Kathleen Burlew notes, as Volkow does, that when Black patients enter find a halfway house – forexdata treatment, they are more likely to do so later than white people and are less likely to complete it. In addition to mistrust, she says, the less favorable outcomes result from factors such as clinician bias and lack of racial and ethnic diversity among treatment providers. But despite Gooch’s long experience, the opioid epidemic recently has brought a level of devastation to the Black community that has shocked him.

Offering structural support such as housing assistance, transportation assistance, and childcare to help reduce barriers to accessing and staying in treatment and recovery. Identify and address cultural, economic, and structural reasons that increase risk for overdose and prevent certain groups from getting and staying in treatment and recovery. Overdose deaths increased more for certain groups than others from 2019 to 2020.

heroin addiction by race

Marijuana was the most common illicit drug used among AI/AN people aged 12 or older, followed by psychotherapeutic drugs and hallucinogens. The most commonly used illicit drug among pregnant women aged 15 to 44 was marijuana. Opioid types can be further disaggregated during the period 1999–2015, due to the ICD-10 coding details . In addition to heroin and methadone, the ICD-10 also identifies opium , natural/semi-synthetic opioids (e.g., oxycodone and hydrocodone), synthetic opioids other than methadone (e.g., fentanyl and tramadol), and unspecified opioids.

Main and Interactive Effects of Gender and Race/Ethnicity on Drug Abuse

An antiracist public health approach that explicitly examines the role of racism is urgently needed in research, public health, and policy approaches to address the crisis of opioid-related harms. In the planning stage, community coalitions requested data by race/ethnicity to focus on equity. While many public health policies in the US have begun to address the opioid overdose crisis, these policies likely benefit Whites more than Blacks, for whom numerous forms of disparities confer additional risk (e.g., poorer access to housing, employment, and healthcare).

We aimed to model whether unsupervised iOAT may be effective in reducing fatal and non–fatal overdose, and estimate the cost per life saved. Reduce stigma around seeking substance chronic heavy drinking leads to serious risk of dementia, study warns use disorder treatment, harm reduction, and recovery support services. Overdose death rates in older Black men were nearly seven times as high as those in older White men in 2020.

For whites, African Americans, and American Indians, opioids are the leading cause of drug overdose deaths. Over the past 17 years, however, there were increases in all drug categories, including benzodiazepines, psychostimulants (e.g., methamphetamine), heroin and synthetic opioids (e.g., fentanyl and fentanyl analogues). Each of the observed increases in drug categories within racial groups was statistically significant, meaning there is evidence against the can i drink alcohol during pregnancy rates being similar between years. Opioid-involved overdose death rates in the United States differ by demographic and geographic characteristics. Illicitly manufactured fentanyl and fentanyl analogs have fueled recent increases in opioid-involved overdose deaths. In 2017, synthetic opioids were involved in nearly 60% of opioid-involved overdose deaths; however, the level of involvement by racial/ethnic age groups in metropolitan areas has not been explored.

These findings underscore the changing demographics and populations affected by the opioid overdose epidemic as the illicit drug supply continues to evolve. Drug overdose data show troubling trends and widening disparities between different population groups. In just one year, overdose death rates increased 44% for Black people and 39% for American Indian and Alaska Native (AI/AN) people. Most people who died by overdose had no evidence of substance use treatment before their deaths.

Addiction Among Asian Americans/Native Hawaiians and Other Pacific Islanders

“Treatments are extraordinarily useful in terms of preventing overdose death so you can actually recover. Five years can make the difference between being alive or not.” Black people with substance use problems are afraid of being caught up in a punitive criminal justice system and are less likely to have insurance good enough to allow them to seek help on their own. And the COVID pandemic disrupted many recovery and harm-reduction services, particularly for people of color. Psychostimulants, synthetic opioids, and heroin can be injected into the bloodstream through a vein. The increases in psychostimulant-, synthetic opioid-, and heroin-involved deaths points to an increase in injection drug use, because injection is a common way to put these drugs into the body. Injection drug use brings additional risk factors including the spread of infectious diseases and additional physical health problems.

  • Even though there is no difference along racial lines in who uses illegal drugs, Black people nonetheless were arrested for drug offenses at five times the rate of white people in 2016.
  • 10.3 million people (61.6% of the community) had a substance use disorder or mental illness in the past year.
  • Opioid involved overdoses are at an all-time high in the US, with deaths among Black Americans growing at a faster rate than Whites.
  • At the same time, the joinpoint model allows for quantitative identification of time‐points where there are changes to the trend, which is a benefit not offered by conventional forms of regression.

The third wave started in 2013 as a result of synthetic opioids, including illicitly manufactured fentanyl, which has particularly high potential to cause overdose. The United States has been battling an increasingly worsening opioid-related overdose crisis for the past two decades. Though death rates are currently at record highs, population-level overdose rates dropped slightly between 2017 and 2018 just prior to the COVID-19 pandemic, giving communities and public health experts hope we had turned a corner in the crisis. However, given Whites in the United States have historically higher rates of opioid use and comprise the majority of the population in all 48 contiguous US states, reductions in opioid-involved overdose deaths only among Whites were found to be driving the observed changes between 2017 and 2018. While deaths among Whites decreased during this period, opioid overdose deaths among Black and Hispanic Americans increased, leading the Substance Abuse and Mental Health Services Administration to publish a special report highlighting this alarming trend.

Finally, with a response rate of 66%, a non-response bias may have affected our findings. In an effort to assess the possible impact of non-response bias, we conducted a brief telephone survey with a randomly selected sample of students who did not respond to the original survey. A total of 159 students responded to the follow-up effort and we found no significant differences in the rates of alcohol and other drug use for those who responded to the short survey compared to students who completed the original web survey. The illicit use of prescription drugs was second only to marijuana use across both genders and all racial groups; our findings are consistent with an emerging national trend in this age group (e.g., Johnston et al., 2004; McCabe et al., 2007; Mohler-Kuo et al., 2003).

Password Changed Successfully

LegitScript is a third-party certification that demonstrates Footprints complies with all applicable laws and regulations, including our ongoing commitment to transparency. The Joint Commission for the Accreditation of Healthcare Organizations evaluates quality of care provided by healthcare organizations. Early risk factors, like trauma, mental illness, or family problems, may exacerbate the likelihood for developing addiction. References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Reduce adverse childhood experiences and root causes of health disparities. Improving access to programs that address past and prevent future trauma and other risk factors for substance use.

Raise awareness about the dangers of illicitly manufactured fentanyls and using more than one drug. Linking people to treatment from a variety of settings and through trusted messengers, which helps people to continue treatment over time. This study used publicly available deidentified data and was deemed exempt from review by the National Institutes of Health Institutional Review Board. Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at /us). Scientific American maintains a strict policy of editorial independence in reporting developments in science to our readers. Much of the data for AI/ANs from the 2020 survey—especially compared to the other demographic groups—was unavailable due to low precision.

heroin addiction by race

Many addiction treatment programs are faith-based and see addiction as a moral problem, which leads to the conclusion that relying on medication for abstinence or sobriety simply trades one form of addiction for another. Many general practitioners who lack training in addiction medicine have this misconception. The nation’s historic reluctance to treat addiction as a health-care issue rather than a criminal justice one has resulted in a health-care system where too few people of any race—just 10 percent—receive treatment for substance use disorder. Several factors, such as stigma and an inability to afford or access care, make the numbers considerably more dismal among people of color.

These numbers underscore the need for a racially inclusive approach to addressing the opioid crisis, and we are committed to that path, so that no one is left behind. French MT, Roebuck MC, McGeary KA, Chitwood DD, McCoy CB. Using the Drug Abuse Screening Test (DAST-10) to analyze health services utilization and cost for substance users in a community-based setting. Cone EJ, Fant RV, Rohay JM, Caplan YH, Ballina M, Reder RF, Haddox JD. Oxycodone involvement in drug abuse deaths.

Change Password

Injecting in public places may increase the risk of drug and health-related harms among people who inject drugs . We examined the prevalence of public injecting and associations with non–fatal overdose, needle/syringe sharing, sexual health, and mental health among PWID in Iran. Holistic health care systems can best address the needs of aging PWID with integrated care that provides harm reduction, substance use and mental health treatment together, and wrap around services. In Minnesota, factors like systemic racism have prevented communities of color from having equal access to the resources needed to be healthy. Poverty, ACEs, intergenerational trauma, and intergenerational substance use are all social determinants of health influenced by systemic racism.

Differences in Rates of Drug Overdose Deaths by Race

In addition, two national studies and one single institution study showed that undergraduate college men were more likely than women to report nonmedical use of prescription stimulants (Johnston et al., 2005a; McCabe et al., 2005a; Teter et al., 2005). At the state level, in wave 1, African Americans had a smaller average annual percentage change compared to Whites in eight of the 10 states studied. In wave 2, 11 of 21 states had a higher average annual percentage change in opioid overdose death for African Americans compared to Whites. During wave 3, the racial disparity persisted in nine of the 11 states from wave 2 and increased by an additional four states, leading to a higher average annual percentage change in opioid overdose deaths in African Americans compared with Whites in 13 of 21 states (61.9%). In light of the escalating opioid crisis, understanding how racial-ethnic groups may be differentially affected is key to tailoring support and services.

Delva J, Smith MP, Howell RL, Harrison DF, Wilke D, Jackson DL. A study of the relationship between protective behaviors and drinking consequences among undergraduate college students. In 2007, unintentional drug poisoning became the leading cause of injury death in Ohio, surpassing motor vehicle crashes for the first time on record. The ODH Violence and Injury Prevention Section collects and utilizes surveillance data to inform prevention programs with the goal of reducing overdose-related fatalities. M. R. Larochelle received consulting funds for research on opioid use disorder treatment pathways paid to his institution from OptumLabs. All of the authors made substantial contributions to this brief and were involved in editorial preparation and review. Gioncarlo Valentine is an award-winning photographer and writer from Baltimore.

Leave a Comment

Your email address will not be published.